The creators of Sintesi, the designer robotic digital gym that revolutionizes fitness and rehabilitation for personalized and effective workouts.
International patent, proprietary technologies and Italian design.
Average annual growth rate of 65% from 2020.
Over 500 machines sold worldwide.
4.1 Mln in sales from 2020 to date.
Goal min 800 k€
Goal max 1,5 Mln€
AKUIS was born out of the vision of Alessandro Englaro and Mattiarmando Chiavegato, the former an aerospace engineer, the latter an architect-designer, to revolutionize the workout experience by making it personalized and more engaging.
From this idea was born Sintesi, a cable and digital load robotic machine, an all-in-one digital gym. Lightweight and versatile, it consists of two tubular modules, weighing less than 10 kg, that can be placed either on the wall or on the floor and offers a customized workout with a variety of programmable resistances.
Designed for fitness professionals, personal trainers, physical therapists, and home fitness enthusiasts, Sintesi allows for more than 200 exercises and full-body programs, as well as functional workouts for many sports, all managed through a mobile app that provides real-time data and detailed reports.
The tailored approach ensures workouts optimized for maximum effectiveness, leading to tangible results: whether it's developing strength, recovering from injury or improving overall fitness, Synthesis is designed to help users achieve their goals effectively and efficiently with challenging but safe sessions.
More than 500 fitness professionals and athletes worldwide have already chosen Sintesi. Akuis' turnover has grown exponentially, from €500,000 in 2020 to €1,334,000 in 2022, with the goal of approaching €2,000,000 in 2023.
The combination of advanced technology and made-in-Italy design makes Sintesi unique, setting it apart from its main European competitors.
Its technology is the result of constant research, focused on the specific needs of fitness professionals and end users. The engineering team has worked extensively to develop a machine that not only meets but exceeds market expectations, devising unique solutions such as Dynamic Vectoring, which is protected with a worldwide patent.
Akuis' commitment to providing an outstanding product is also demonstrated by its customer service. The company offers comprehensive support, from training on machine use to troubleshooting, ensuring that every experience with Sintesi is positive and productive.
Sintesi is not just a product; it represents a new vision for the fitness world.
With Sintesi, Akuis is transforming the health and training industry by improving performance and wellness for clients with a clear mission: to improve the quality of life and well-being of clients through targeted and engaging training.
The Mamacrowd campaign will support marketing to increase brand visibility in Europe and expand the customer base, strengthen the medical sales team, and fund new product development.
Tax benefits of 30 percent apply on Akuis.
Akuis reserves the right of "liquidation preference" for all investors who join the campaign, who will therefore be reimbursed first in the event of an exit compared to the company's other shareholders (according to the order of preference indicated in the bylaws). All conditions are published in the bylaws found in the Documents section.
This is a marketing communication. Equity crowdfunding investments are high-risk and could result in full or partial loss of invested capital. Please read the sheet containing key investment information before joining.
Warnings pursuant to Article 19(2)
crowdfunding services provided by Mamacrowd are not covered by the Deposit Guarantee Scheme established in accordance with Directive 2014/49/EU*; securities and instruments eligible for crowdfunding purposes that can be acquired through this crowdfunding platform are not covered by the Investor Compensation Scheme established in accordance with Directive 97/9/EC**.
* Directive 2014/49/EU of the European Parliament and of the Council on Deposit Guarantee Schemes.
** Directive 97/9/EC of the European Parliament and of the Council on investor-compensation schemes.
© 2023 SiamoSoci Srl a company of Azimut Group - VAT number IT07464370969 - Via Timavo 34, 20124 MI - SC € 95.417,54 fully paid up - Registr. 8, resolution 19002 of 06/08/14